Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reversal of dabigatran anticoagulant effect by Beriplex using shed blood and washed blood methods
2014-002204-24Phase 2Active
- Sponsor
- University Medical Center Groningen
- Start
- Oct 2014
- Modality
- Blood Coagulation Factors → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of balfaxar in anticoagulation therapy, sponsored by University Medical Center Groningen. Primary endpoint: Shed blood method (Fibrinopeptide A and total blood volume). Started Oct 2014; status: active.
02
Drugs
balfaxar
03
Conditions
anticoagulation therapy
Beyond the preview
Go deeper on 2014-002204-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002204-24.